This is a Validated Antibody Database (VAD) review about human FGFR2, based on 19 published articles (read how Labome selects the articles), using FGFR2 antibody in all methods. It is aimed to help Labome visitors find the most suited FGFR2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FGFR2 synonym: BBDS; BEK; BFR-1; CD332; CEK3; CFD1; ECT1; JWS; K-SAM; KGFR; TK14; TK25

Abcam
domestic rabbit monoclonal (EPR5180)
  • western blot; human; 1:500; loading ...; fig 2k
Abcam FGFR2 antibody (Abcam, ab109372) was used in western blot on human samples at 1:500 (fig 2k). Aging (Albany NY) (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 5b
  • western blot; mouse; loading ...; fig 5c
Abcam FGFR2 antibody (Abcam, ab10648) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 5b) and in western blot on mouse samples (fig 5c). Evid Based Complement Alternat Med (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 1b
Abcam FGFR2 antibody (Abcam, ab10648) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1b). PLoS ONE (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 4a
Abcam FGFR2 antibody (Abcam, ab10648) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 4a). Stem Cells Transl Med (2019) ncbi
domestic rabbit polyclonal
  • flow cytometry; mouse; loading ...; fig st1
In order to study how bone marrow endothelial cells regulate bone marrow stem cell maintenance and leukocyte trafficking, Abcam FGFR2 antibody (Abcam, Ab10648) was used in flow cytometry on mouse samples (fig st1). Nature (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; rat; fig 7
  • western blot; rat; 1:2000; fig 7
Abcam FGFR2 antibody (abcam, ab10648) was used in immunocytochemistry on rat samples (fig 7) and in western blot on rat samples at 1:2000 (fig 7). Sci Rep (2016) ncbi
Abnova
mouse monoclonal (1G3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2d
Abnova FGFR2 antibody (Abnova, H00002263-M01) was used in immunohistochemistry - paraffin section on human samples (fig 2d). Cancers (Basel) (2020) ncbi
mouse monoclonal (1G3)
  • immunohistochemistry - paraffin section; human; 1:600; loading ...; fig 6c, 6d
Abnova FGFR2 antibody (Abnova, H00002263-M01) was used in immunohistochemistry - paraffin section on human samples at 1:600 (fig 6c, 6d). Oncotarget (2016) ncbi
mouse monoclonal (1G3)
  • immunohistochemistry - paraffin section; human; 1:3000; tbl 1
Abnova FGFR2 antibody (Abnova, H2263-M01) was used in immunohistochemistry - paraffin section on human samples at 1:3000 (tbl 1). Cancer Res Treat (2016) ncbi
mouse monoclonal (1G3)
  • immunohistochemistry - paraffin section; human; 1:500; fig 5
Abnova FGFR2 antibody (Abnova, H00002263-M01) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 5). J Stroke Cerebrovasc Dis (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (C-8)
  • western blot; mouse; loading ...; fig 6a
Santa Cruz Biotechnology FGFR2 antibody (Santa Cruz, sc-6930) was used in western blot on mouse samples (fig 6a). Int J Mol Sci (2021) ncbi
mouse monoclonal (C-8)
  • western blot; human; 1:500; loading ...; fig 4b
Santa Cruz Biotechnology FGFR2 antibody (SantaCruz, sc-6930) was used in western blot on human samples at 1:500 (fig 4b). Oncol Lett (2017) ncbi
mouse monoclonal (C-8)
  • immunocytochemistry; human; loading ...; fig 5b
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology FGFR2 antibody (Santa Cruz Biotechnology, sc-6930) was used in immunocytochemistry on human samples (fig 5b) and in western blot on human samples (fig 5a). Mol Cell Biochem (2015) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 2e, 2f
Invitrogen FGFR2 antibody (Thermo Fisher, PA5-64796) was used in western blot on mouse samples at 1:1000 (fig 2e, 2f). Sci Rep (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 2e, 2f
Invitrogen FGFR2 antibody (Thermo Fisher, PA5-14651) was used in western blot on mouse samples at 1:1000 (fig 2e, 2f). Sci Rep (2020) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C51F2)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology FGFR2 antibody (Cell Signaling, 4574) was used in western blot on human samples (fig 4b). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (D4L2V)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology FGFR2 antibody (Cell Signaling Technology, 23328) was used in western blot on human samples (fig 3b). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (C51F2)
  • immunohistochemistry; human; fig 6a
  • western blot; human; fig 4a
Cell Signaling Technology FGFR2 antibody (Cell Signaling, C51F2) was used in immunohistochemistry on human samples (fig 6a) and in western blot on human samples (fig 4a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (C51F2)
  • western blot; human
Cell Signaling Technology FGFR2 antibody (Cell Signaling, 4574) was used in western blot on human samples . J Thyroid Res (2014) ncbi
domestic rabbit monoclonal (C51F2)
  • western blot; human
In order to study mechanism of resistance to the FGFR inhibitor BGJ398 and the FGFR inhibitor ponatinib, Cell Signaling Technology FGFR2 antibody (cell signaling, 4574S) was used in western blot on human samples . Oncogene (2015) ncbi
Articles Reviewed
  1. Rajendran R, Rajendran V, Giraldo Velasquez M, Megalofonou F, Gurski F, Stadelmann C, et al. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. Int J Mol Sci. 2021;22: pubmed publisher
  2. Guo T, Gu C, Li B, Xu C. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain. Aging (Albany NY). 2021;13:19750-19759 pubmed publisher
  3. Braun M, Piasecka D, Tomasik B, Mieczkowski K, Stawiski K, Zielińska A, et al. Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma. Cancers (Basel). 2020;12: pubmed publisher
  4. Wang Y, Liao Q, Tang S, Cai Z, Zhang H. Gubenzhike Recipe Ameliorates Respiratory Mucosal Immunity in Mice with Chronic Obstructive Pulmonary Disease through Upregulation of the γδT Lymphocytes and KGF Levels. Evid Based Complement Alternat Med. 2020;2020:3056797 pubmed publisher
  5. Ichikawa K, Watanabe Miyano S, Minoshima Y, Matsui J, Funahashi Y. Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy. Sci Rep. 2020;10:2939 pubmed publisher
  6. Jun B, Lee W, Jang J, Jeong S, Chang Y, Lee S, et al. Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection. PLoS ONE. 2020;15:e0227440 pubmed publisher
  7. Si J, Ma Y, Bi J, Xiong Y, Lv C, Li S, et al. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties. J Exp Clin Cancer Res. 2019;38:481 pubmed publisher
  8. Villani V, Thornton M, Zook H, Crook C, Grubbs B, Orlando G, et al. SOX9+/PTF1A+ Cells Define the Tip Progenitor Cells of the Human Fetal Pancreas of the Second Trimester. Stem Cells Transl Med. 2019;8:1249-1264 pubmed publisher
  9. Hori A, Shimoda M, Naoi Y, Kagara N, Tanei T, Miyake T, et al. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer. Breast Cancer Res. 2019;21:88 pubmed publisher
  10. Yang W, Wang X, Yuan H, Liu Z, Gao S, Peng L. Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma. Oncol Lett. 2017;13:3198-3204 pubmed publisher
  11. Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L, et al. Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells. Oncotarget. 2016;7:86011-86025 pubmed publisher
  12. Itkin T, Gur Cohen S, Spencer J, Schajnovitz A, Ramasamy S, Kusumbe A, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532:323-8 pubmed publisher
  13. Tong L, Zhou J, Rong L, Seeley E, Pan J, Zhu X, et al. Fibroblast Growth Factor-10 (FGF-10) Mobilizes Lung-resident Mesenchymal Stem Cells and Protects Against Acute Lung Injury. Sci Rep. 2016;6:21642 pubmed publisher
  14. Inaguma S, Ito H, Riku M, Ikeda H, Kasai K. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. Oncotarget. 2015;6:28257-68 pubmed publisher
  15. Litwin M, Radwańska A, Paprocka M, Kieda C, Dobosz T, Witkiewicz W, et al. The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production. Mol Cell Biochem. 2015;410:131-42 pubmed publisher
  16. Park S, Nam S, Keam B, Kim T, Jeon Y, Lee S, et al. VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma. Cancer Res Treat. 2016;48:518-26 pubmed publisher
  17. Tohyama O, Matsui J, Kodama K, Hata Sugi N, Kimura T, Okamoto K, et al. Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. J Thyroid Res. 2014;2014:638747 pubmed publisher
  18. Wang J, Mikse O, Liao R, Li Y, Tan L, Jänne P, et al. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene. 2015;34:2167-77 pubmed publisher
  19. Katano H, Yamada K. Upregulation of ANGPTL4 messenger RNA and protein in severely calcified carotid plaques. J Stroke Cerebrovasc Dis. 2014;23:933-47 pubmed publisher